Dasatinib in Advanced Squamous Cell Lung Cancer

This study has been terminated.
(Safety issues/concerns per DF/HCC PI)
Sponsor:
Information provided by (Responsible Party):
Bruce Johnson, MD, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT01491633
First received: October 5, 2011
Last updated: February 13, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2013
  Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)